Company intelligence / Profile preview

IOMED

Barcelona, Catalonia, Spainiomed.health ↗

Ownership: Private
Development stage: Commercial

Overview

IOMED operates a commercial AI-powered health data platform that structures both structured and unstructured clinical information using NLP. The system enables compliant secondary use of real-world health data for clinical research, observational studies, feasibility analysis, and more. It has been deployed in numerous hospitals across Europe with over 21 million patients' records accessible through its federated network.

Modalities: Non-pharmacological therapy (data platform)Artificial IntelligenceNatural Language Processing (NLP)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

EHDEN Network/OHDSI Partners

Beyond the preview

Go deeper on IOMED.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IOMED.

Explore the full profile